Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shannon

Showing results (341-350 of 987) with videos related to

Pageof 99
Sort By:
AORN Journal|November 1, 1987
Comments on potential lead hazards articleS Geyer, S B Lee, P G Lacouture, et al.
Journal of Medicinal Chemistry|March 1, 1974
Antiviral agents. 1-AralkyloxyadenosinesW M Shannon, A Shortnacy, G Arnett, et al.
The American Journal of Emergency Medicine|July 1, 1990
Serum magnesium concentrations after repetitive magnesium cathartic administrationJ A Woodard, M Shannon, P G Lacouture, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
A 32-year-old man with progressive spasticity and parkinsonismS Frucht, S Fahn, K M Shannon, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|September 19, 2000
Tandem zinc-finger gene families in mammals: insights and unanswered questionsM Shannon, J Kim, L Ashworth, et al.
International Journal of Offender Therapy and Comparative Criminology|August 2, 2019
Examining Predisposing Factors and Program Performance Indicators Associated With Program Completion: A Comparison of Opioid and Non-Opioid-Preferring Participants in Drug CourtLisa M Shannon, Afton Jackson Jones, Jennifer Newell, et al.
Congenital Heart Disease|April 3, 2008
A pediatric case report on arrhythmogenic right ventricular dysplasiaEllen L P Chan, Kevin M Shannon, Thomas S Klitzner
Development (Cambridge, England)|May 11, 2000
A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1S M Robertson, M Kennedy, J M Shannon, et al.
Blood|November 15, 1994
Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21rasR Kalra, D C Paderanga, K Olson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 31, 2007
Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patientKatie Kompoliti, Yaping Chu, Kathleen M Shannon, et al.
Pageof 99

Showing results (341-350 of 987) with videos related to

Sort By:
Pageof 99
AORN Journal|November 1, 1987
Comments on potential lead hazards articleS Geyer, S B Lee, P G Lacouture, et al.
Journal of Medicinal Chemistry|March 1, 1974
Antiviral agents. 1-AralkyloxyadenosinesW M Shannon, A Shortnacy, G Arnett, et al.
The American Journal of Emergency Medicine|July 1, 1990
Serum magnesium concentrations after repetitive magnesium cathartic administrationJ A Woodard, M Shannon, P G Lacouture, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
A 32-year-old man with progressive spasticity and parkinsonismS Frucht, S Fahn, K M Shannon, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|September 19, 2000
Tandem zinc-finger gene families in mammals: insights and unanswered questionsM Shannon, J Kim, L Ashworth, et al.
International Journal of Offender Therapy and Comparative Criminology|August 2, 2019
Examining Predisposing Factors and Program Performance Indicators Associated With Program Completion: A Comparison of Opioid and Non-Opioid-Preferring Participants in Drug CourtLisa M Shannon, Afton Jackson Jones, Jennifer Newell, et al.
Congenital Heart Disease|April 3, 2008
A pediatric case report on arrhythmogenic right ventricular dysplasiaEllen L P Chan, Kevin M Shannon, Thomas S Klitzner
Development (Cambridge, England)|May 11, 2000
A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1S M Robertson, M Kennedy, J M Shannon, et al.
Blood|November 15, 1994
Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21rasR Kalra, D C Paderanga, K Olson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 31, 2007
Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patientKatie Kompoliti, Yaping Chu, Kathleen M Shannon, et al.
Pageof 99